PHOENIX AUTOCALLABLE WORST OF - GSK PLC ADR/ROCHE GS/NOVO NORDISK ADR B PHOENIX AUTOCALLABLE WORST OF - GSK PLC ADR/ROCHE GS/NOVO NORDISK ADR B Stock
Certificat
IT0005586828
| Market Closed - Wiener Boerse 20:30:00 2024-06-13 EDT | ||
| 100 EUR | 0.00% |
|
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
Static data
| Product type | Other Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | NOVO NORDISK A/S |
| Issuer | Intesa Sanpaolo |
| IT0005586828 | |
| ISIN | IT0005586828 |
| Date issued | 2024-03-20 |
| Maturity | 2027-03-16 (1003 Days) |
| Parity | 1 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Spread | 1.01 € |
|---|---|
| Spread % | 1.00% |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
991
DKK
Average target price
934.3
DKK
Spread / Average Target
-5.72%
- Stock Market
- Certificates
- IT0005586828 Certificat
